Clinical Trials Sponsored by NoNO Inc.
Total 37139 results
-
NoNO Inc.RecruitingFirst-In-Human Study to Evaluate Safety of a New Drug Intended for Treatment of Acute Ischemic StrokeCanada
-
NoNO Inc.WithdrawnSubarachnoid Hemorrhage | Ruptured Intracranial AneurysmCanada, United States
-
NoNO Inc.University of CalgaryCompletedStroke, AcuteUnited States, Canada, Singapore, Netherlands, Germany, Switzerland, Australia, Norway, Italy
-
NoNO Inc.Arbor Vita CorporationCompleted
-
NoNO Inc.University of CalgaryCompletedStroke, AcuteUnited States, Ireland, Korea, Republic of, Canada, Sweden, Germany, United Kingdom, Australia
-
Ono Pharma USA IncCompletedMajor Depressive DisorderUnited States
-
Ono Pharma USA IncTerminatedChemotherapy-Induced ThrombocytopeniaUnited States, Korea, Republic of, Russian Federation
-
Ono Pharma USA IncOno Pharmaceutical Co. LtdCompleted
-
Ono Pharma USA IncCompletedPostoperative Supraventricular Tachyarrythmia
-
Ono Pharma USA IncCompleted
-
Ono Pharma USA IncCompletedHealthy Adult SubjectsUnited States
-
Ono Pharma USA IncCompletedIrritable Bowel Syndrome (IBS)United States
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
Ono Pharma USA IncOno Pharmaceutical Co. LtdCompletedHealthy | Hepatic ImpairmentUnited States
-
Ono Pharma USA IncCompletedOcular Hypertension (OHT) | Mild Open Angle-glaucoma (OAG)United States
-
Ono Pharma USA IncTerminatedCerebrovascular AccidentUnited States, Canada
-
Ono Pharma USA IncCompletedHealthy Adult SubjectsUnited States
-
Ono Pharma USA IncCompleted
-
Ono Pharma USA IncCompletedAlzheimer's DiseaseUnited States, Canada
-
Ono Pharma USA IncCompletedHealthy Adult SubjectsUnited States
-
Astellas Pharma IncOno Pharma USA IncCompletedBone Diseases | Osteoporosis | Osteoporosis, PostmenopausalJapan
-
Ono Pharma USA IncTerminatedIrritable Bowel Syndrome (IBS)United States
-
Ono Pharma USA IncOno Pharmaceutical Co. LtdCompleted
-
Ono Pharma USA IncOno Pharmaceutical Co. LtdCompleted
-
Ono Pharma USA IncCompletedDiabetes Mellitus, Type 2United States
-
Ono Pharma USA IncCompleted
-
Ono Pharma USA IncCompletedOsteoporosis | OsteopeniaNetherlands
-
Tahitian Noni International, Inc.Indonesia UniversityCompletedQuality of Life | Metabolic Syndrome | Oxidative StressIndonesia
-
Tahitian Noni International, Inc.TNO-BIBRACompleted
-
Forma Therapeutics, Inc.Medpace, Inc.CompletedHealthy Volunteers | Sickle Cell DiseaseUnited States
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingEnd Stage Renal Disease | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1Germany, Spain, United States, United Kingdom, Italy, United Arab Emirates, Lebanon, Morocco, France, Romania
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingAlpha 1-Antitrypsin DeficiencyUnited Kingdom, United States, Ireland, Belgium, New Zealand, Spain, Netherlands, Portugal, Canada, Australia, France, Austria, Germany, Sweden
-
Forma Therapeutics, Inc.Novo Nordisk A/SRecruitingSickle Cell DiseaseLebanon, Canada, Kenya, United Kingdom
-
Forma Therapeutics, Inc.Novo Nordisk A/SRecruiting
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingPrimary Hyperoxaluria Type 3 | Primary Hyperoxaluria Type 2 | Primary Hyperoxaluria Type 1 | Primary HyperoxaluriaUnited States, Canada, Lebanon, Turkey, United Kingdom, Germany, Italy, Japan, Poland, Spain, United Arab Emirates
-
Forma Therapeutics, Inc.RecruitingSickle Cell Disease | ThalassemiaUnited States, Lebanon, Canada
-
Forma Therapeutics, Inc.Novo Nordisk A/SRecruitingSickle Cell DiseaseUnited States, Italy, Spain, United Kingdom, France, Lebanon, Germany, Oman, Canada, Greece
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyActive, not recruitingPrimary Hyperoxaluria Type 3United States, Germany, United Kingdom, Canada, Poland
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Forma Therapeutics, Inc.CompletedCohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme) | Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) | Cohort 3a and 3b: Chondrosarcoma | Cohort 4a and 4b: Intrahepatic... and other conditionsUnited States, Korea, Republic of, Australia, United Kingdom, Spain, France
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyAvailablePrimary Hyperoxaluria Type 1 (PH1)
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyRecruitingSolid Tumor, Adult | Refractory TumorUnited States
-
Forma Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States, Spain, Korea, Republic of, Australia, Canada, Germany, France, United Kingdom, Italy
-
Forma Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
University of Central FloridaLake Nona Institute; DataStat, Inc.; Mytrus, Inc.Recruiting
-
Bristol-Myers SquibbOno Pharma USA IncCompletedRenal Cell CarcinomaUnited States, Canada, Italy, Finland
-
Bristol-Myers SquibbOno Pharma USA IncCompleted